CUAMC
SYRS

China Universal Asset Management Company’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

China Universal Asset Management Company’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59
Closed – – 480
2022
Q3 		$0 Buy
+59
New – ﹤0.01% 468